SP Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-42,882
Closed -$415K 143
2025
Q2
$415K Sell
42,882
-6,735
-14% -$69.5K 0.03% 98
2025
Q1
$739K Buy
49,617
+1,389
+3% +$21.4K 0.07% 82
2024
Q4
$720K Buy
48,228
+4,945
+11% +$80.6K 0.06% 85
2024
Q3
$828K Sell
43,283
-1,339
-3% -$27.8K 0.07% 80
2024
Q2
$924K Buy
44,622
+977
+2% +$19.4K 0.08% 78
2024
Q1
$821K Sell
43,645
-1,147
-3% -$19.7K 0.08% 76
2023
Q4
$646K Sell
44,792
-279,282
-86% -$3.8M 0.07% 80
2023
Q3
$5.63M Buy
324,074
+18,218
+6% +$380K 0.63% 35
2023
Q2
$6.36M Buy
305,856
+483
+0.2% +$10.5K 0.71% 34
2023
Q1
$7.18M Sell
305,373
-1,533
-0.5% -$41.2K 0.88% 29
2022
Q4
$8.57M Buy
306,906
+7,635
+3% +$195K 1.15% 28
2022
Q3
$7M Buy
299,271
+133,492
+81% +$4.03M 0.96% 28
2022
Q2
$5.59M Sell
165,779
-5,499
-3% -$193K 0.71% 39
2022
Q1
$5.98M Buy
171,278
+1,436
+0.8% +$49.1K 0.64% 42
2021
Q4
$5.6M Buy
169,842
+60,589
+55% +$1.97M 0.56% 43
2021
Q3
$3.9M Buy
109,253
+83,465
+324% +$2.67M 0.41% 51
2021
Q2
$751K Buy
+25,788
New +$849K 0.08% 78

Other funds holding OGN

SP Asset Management's OGN Position: Q3 2025 in Review

SP Asset Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 42,882 shares — an estimated $415K sold.

SP Asset Management first reported a position in OGN in Q2 2021 and held it in 17 quarters. The position peaked at $8.57M in Q4 2022. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • SP Asset Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • SP Asset Management sold 42,882 Organon & Co shares in Q3 2025, an estimated $415K.
  • SP Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 17 quarters.
  • SP Asset Management's Organon & Co position peaked at $8.57M in Q4 2022.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on SP Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.